OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001

Clinical trial NCT04575259 · COMPLETED

Trial details

NCT number: NCT04575259
Sponsor: Anavex Life Sciences Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease Dementia

Start date: 2019-10-10
Primary completion: 2022-05-31
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.